Pharmaceutical Giant Sees Opportunity in Beauty Industry

A drug that Allergen Pharmaceutical sells to people with certain types of glaucoma and ocular hypertension has shown some very unusual side effects. The drug contains an ingredient called “bimatoprost” that unexpectedly and quite effectively stimulates the growth of eyelashes. Allergan has decided to introduce a bimatoprost containing product called “Latisse” targeted to consumers who …

Pharmaceutical Giant Sees Opportunity in Beauty Industry Read More »

Notable Quotes

On cosmetics: “I think it’s incorrect to say we are self-regulated. The FDA sets out standards for how our products can be put together.” John Hurson, Personal Care Products Council. Source: The Rose Sheet

New Book available on EU Cosmetic Safety

Safety Assessment of Cosmetics in the European Union (S. Karger) is a new book available from Dermato-Cosmetic Sciences. This book deals with many aspects of cosmetic safety assessment, including an overview of the EU legislation on cosmetics, SCCP safety assessments, searches for toxicological data in databases and the challenges of applying alternative methods in safety …

New Book available on EU Cosmetic Safety Read More »

Progress Report: International Cooperation of Cosmetic Regulation (ICCR)

Substantial progress is being made toward establishing a system of globalization for cosmetic regulations. The group working to achieve this important goal is called the International Cooperation on Cosmetic Regulations (ICCR). More Info: A progress update can be found at

CTTFA Exploring Siloxane Question

The Canadian Cosmetic, Toiletry and Fragrance Association (CCTFA) held a meeting with the Environment Canada scientists responsible for drafting the reports pertaining to three cyclic siloxanes (D4/D5/D6). These three are cosmetic ingredients used widely in many common products used around the world, including shampoos, hair conditioners and skin products. The goal of the CCTFA meeting …

CTTFA Exploring Siloxane Question Read More »

The FDA Globalization Act of 2008

The U.S. House Committee on Energy and Commerce is proposing legislation entitled “The FDA Globalization Act of 2008.” The legislation intent is to stimulate discussion about ways to provide adequate funding for the FDA and contains several provisions that are sure to impact the cosmetics industry. The most important changes related to cosmetics would be: …

The FDA Globalization Act of 2008 Read More »

REACH Update

REACH legislation is evolving all the time, as is its effect on our industry. Big changes will be coming over the next few years, so make sure to keep up to date. REACH applies to all chemicals that are marketed or manufactured in the European Union, with few exceptions. Cosmetics, beauty and personal care products …

REACH Update Read More »

U.S. House of Representatives Fails to Develop Nanotech Safety Research Plan

A subcommittee chaired by Representative Brian Baird has failed to develop a detailed plan for assessing the environmental and health impact posed by nanotechnology. “I am generally puzzled why more progress has not been made to develop this research strategy… necessary for successful development of nanotechnology.”  click to read more of this article At the …

U.S. House of Representatives Fails to Develop Nanotech Safety Research Plan Read More »